179 related articles for article (PubMed ID: 31319019)
1. Identification of Phenylpyrazolone Dimers as a New Class of Anti-Trypanosoma cruzi Agents.
Sijm M; Siciliano de Araújo J; Ramos Llorca A; Orrling K; Stiny L; Matheeussen A; Maes L; de Esch IJP; de Nazaré Correia Soeiro M; Sterk GJ; Leurs R
ChemMedChem; 2019 Sep; 14(18):1662-1668. PubMed ID: 31319019
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi.
Sijm M; Sterk GJ; Caljon G; Maes L; de Esch IJP; Leurs R
ChemMedChem; 2020 Jul; 15(14):1310-1321. PubMed ID: 32249532
[TBL] [Abstract][Full Text] [Related]
3. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
5. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
7. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
Batista DDGJ; de Almeida Fiuza LF; Klupsch F; da Costa KN; Batista MM; da Conceição K; Bouafia H; Vergoten G; Millet R; Thuru X; Bailly C; Soeiro MNC
Exp Parasitol; 2024 Jul; 262():108787. PubMed ID: 38759776
[TBL] [Abstract][Full Text] [Related]
8. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
9. Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against
Lara LS; Lechuga GC; Moreira CDS; Santos TB; Ferreira VF; da Rocha DR; Pereira MCS
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467422
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
de Araújo JS; França da Silva C; Batista DDGJ; Nefertiti A; Fiuza LFA; Fonseca-Berzal CR; Bernardino da Silva P; Batista MM; Sijm M; Kalejaiye TD; de Koning HP; Maes L; Sterk GJ; Leurs R; Soeiro MNC
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601163
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.
Ponzi S; Bresciani A; Kaiser M; Nardi V; Nizi E; Ontoria JM; Pace P; Paonessa G; Summa V; Harper S
Bioorg Med Chem Lett; 2020 Apr; 30(8):127052. PubMed ID: 32113841
[TBL] [Abstract][Full Text] [Related]
12. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
[TBL] [Abstract][Full Text] [Related]
14. Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against
Orlando LMR; Lechuga GC; da Silva Lara L; Ferreira BS; Pereira CN; Silva RC; Dos Santos MS; Pereira MCS
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771151
[TBL] [Abstract][Full Text] [Related]
15. In vitro, ex vivo and in vivo short-term screening of DHEA nitrate derivatives activity over Trypanosoma cruzi Ninoa and TH strains from Oaxaca State, México.
Domínguez-Díaz LR; Eugenia Ochoa M; Soto-Castro D; Farfán N; Morales-Chamorro M; Yépez-Mulia L; Pérez-Campos E; Santillan R; Moreno-Rodríguez A
Bioorg Med Chem; 2021 Oct; 48():116417. PubMed ID: 34571489
[TBL] [Abstract][Full Text] [Related]
16. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
[TBL] [Abstract][Full Text] [Related]
17. Insights into Anti-Trypanosomal Agents Based on Synthetic Glycoconjugates.
Campo VL; Marchiori MF; Carvalho I
Curr Top Med Chem; 2018; 18(5):382-396. PubMed ID: 29741138
[TBL] [Abstract][Full Text] [Related]
18. Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
Álvarez G; Martínez J; Varela J; Birriel E; Cruces E; Gabay M; Leal SM; Escobar P; Aguirre-López B; Cabrera N; Tuena de Gómez-Puyou M; Gómez Puyou A; Pérez-Montfort R; Yaluff G; Torres S; Serna E; Vera de Bilbao N; González M; Cerecetto H
Eur J Med Chem; 2015 Jul; 100():246-56. PubMed ID: 26094151
[TBL] [Abstract][Full Text] [Related]
19. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
20. Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening.
Bettiol E; Samanovic M; Murkin AS; Raper J; Buckner F; Rodriguez A
PLoS Negl Trop Dis; 2009; 3(2):e384. PubMed ID: 19238193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
